Search Results for "Law Firm Representing Glaxo Smith Kline"

17:31 EDT 20th October 2016 | BioPortfolio

Matching Channels


KIACTA™ (also known as eprodisate) is an orally bioavailable small molecule intended for the treatment of AA amyloidosis, an orphan indication that results from long-standing inflammatory cond...

Heat shock protein 90 Hsp90

Inhibition of heat shock protein 90 (Hsp90) results in the degradation of oncoproteins that drive malignant progression, inducing cell death, making Hsp90 a target of substantial interest for cancer...

Bone morphogenetic protein rhBMP

Bone morphogenetic protein 2 (rhBMP-2) is approved by the Food and Drug Administration for anterior lumbar interbody fusion and for acute open tibial fractures; rhBMP-7, on the other hand, is approved...

SureSeq Solid Tumour Panel Sequencing Service

The SureSeq Solid Tumour Panel Sequencing Service utilises an enrichment panel comprising the full coding regions of 58 prioritised cancer genes. The aim of the panel is to improve cancer care by pr...

Matching News

Kline Group: 2015 OTC sales up, but marketing support may be waning

Sales of OTC products were up a solid 4% in 2015, according to the recently published Kline Group Nonprescription Drugs USA report, the company noted in its blog Friday. However, marketing  suppo...

Kline Group projects 2.6% CAGR of OTC medicines through 2020

Michael JohnsenAdditional market consolidation and switch opportunities expected to fuel future OTC growth, Kline Group reports. read more

Glaxo Smithkline findet neue Chefin: Andrew Witty steht als Chef des britischen Pharmakonzerns Glaxo ...

Andrew Witty steht als Chef des britischen Pharmakonzerns Glaxo Smithkline bereits länger in der Kritik. Im kommenden März will der Manager seinen Posten aufgeben. Nun hat Glaxo eine Nachfolgerin g....

Kline Group: Probiotics experiencing double-digit growth

Kline Group on Wednesday posted a blog projectign double-digit sales growth of probiotics. "In 2015, according to our recently published Nonprescription Drugs USA and Natural OTCs: Impact of Non-...

Pharmalot, Pharmalittle: Glaxo may have to boost pay for its next CEO

The Glaxo board is exploring a performance-based bonus of up to nine times base salary to be paid the new chief executive in his or her first year.

Supreme Court says Glaxo must face racketeering lawsuits over a diabetes pill

The health plans alleged GlaxoSmithKline Glaxo deliberately concealed significant side effects associated with Avandia.

Glaxo to pay $20 million for bribing doctors in China

The settlement is an outgrowth of the bribery scandal that rocked Glaxo and resulted in a $490 million fine two years ago

Kline: Growth across 'natural OTCs' outpacing overall OTC growth

Michael JohnsenDriven by consumer interest in all things natural, the market for natural OTCs increased by 11.4%, Kline noted, compared with the overall OTC market that grew 4.2% in 2015. read more

Matching PubMed Articles

Sleep Complaints and the 24-h Melatonin Level in Individuals with Smith-Magenis Syndrome: Assessment for Effective Intervention.

Individuals with Smith-Magenis syndrome (SMS) are reported to have a disrupted circadian rhythm. Our aim was to examine problematic sleeping in those attending our sleep clinic for the first time.

Smith-Magenis Syndrome and Social Security Administration's Compassionate Allowances Initiative: An Evaluative Review of the Literature.

The Social Security Administration (SSA) launched the Compassionate Allowances List (CAL) in 2008. This created a mechanism for expediting review and delivery of disability benefits, while decreasing ...

An Extended N-Player Network Game and Simulation of Four Investment Strategies on a Complex Innovation Network.

As computer science and complex network theory develop, non-cooperative games and their formation and application on complex networks have been important research topics. In the inter-firm innovation ...

36th Annual David W. Smith Workshop on Malformations and Morphogenesis: Abstracts of the 2015 annual meeting.

The 36th Annual David W Smith Workshop on Malformations and Morphogenesis was held on August 14-19, 2015 at the Harbourtowne Conference Center in St. Michaels Maryland. The Workshop, which honors the ...

Acute and early outcomes of FIRM-guided rotors-only ablation in patients with non-paroxysmal atrial fibrillation.

Focal impulse and rotor modulation (FIRM)-guided ablation targets sites that are thought to sustain atrial fibrillation (AF).

Search Whole site using Google

Quick Search
Advertisement Advertisement